Vivesto Stock

Vivesto Forward P/E

The Forward P/E Ratio of Vivesto (VIVE.ST) as of Aug 10, 2026 is -0.70. In the previous year, Forward P/E Ratio was -0.25 — a change of 184.08% (lower).

Forward P/E

-0.70

YoY

184.08%

Last updated:

Forward P/E Ratio of Vivesto is 2026 -0.70 . Forward P/E Ratio of Vivesto was 2025 -0.25 . It decreases by 184.08% lower compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

Forward P/E Ratio of Vivesto is -0.70 in 2026.

Forward P/E Ratio of Vivesto changed from -0.25 to -0.70, representing a 184.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Vivesto since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Vivesto with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vivesto

All Key Metrics — Vivesto